Data for (Study ST003049)
(Analysis AN005000)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 |
|---|---|---|
| 11-HDoHE | 0.9013 | 1.0987 |
| 11-HETE | 0.9037 | 1.0963 |
| 12-HEPE | 0.8387 | 1.1613 |
| 12-HETE / 8-HETE | 0.9008 | 1.0992 |
| 12-HETrE | 0.9253 | 1.0747 |
| 12-HHTrE | 0.9079 | 1.0921 |
| 13,14-dihydro-15-keto-PGE2 | 0.9447 | 1.0553 |
| 13,14-dihydro-15-keto-PGF2a | 0.9762 | 1.0238 |
| 13-,16- and 17-HDoHE | 0.9543 | 1.0457 |
| 14-HDoHE and 10-HDoHE | 0.8669 | 1.1331 |
| 15-HETE | 0.8846 | 1.1154 |
| 9- and 13-HODE_9(10)- and 12(13)-EPOME | 0.9432 | 1.0568 |
| 9-HpODE | 1.0000 | 1.0000 |
| Deoxycholic Acid | 0.9904 | 1.0096 |
| Hepoxilin B3 | 0.8855 | 1.1145 |
| HHTrE / isoform I | 0.9339 | 1.0661 |
| HHTrE / isoform II | 0.8975 | 1.1025 |
| HpODE / isoform I | 0.9964 | 1.0036 |
| LPC (0:0/16:0) | 1.0403 | 0.9597 |
| LPC (0:0/18:1) | 1.0311 | 0.9689 |
| LPC (0:0/18:2) | 1.0194 | 0.9806 |
| LPC (0:0/20:4) | 1.0081 | 0.9919 |
| LPC (0:0/22:6) | 1.0205 | 0.9795 |
| LPC (16:0/0:0) | 1.0294 | 0.9706 |
| LPC (18:1/0:0) | 1.0467 | 0.9533 |
| LPC (18:2/0:0) | 1.0463 | 0.9537 |
| LPC (20:4/0:0) | 1.0259 | 0.9741 |
| LPC (22:6/0:0) | 1.0324 | 0.9676 |
| LPE (0:0/16:0) | 1.0002 | 0.9998 |
| LPE (0:0/18:1) | 1.0007 | 0.9993 |
| LPE (0:0/18:2) | 1.0138 | 0.9862 |
| LPE (0:0/20:4) | 0.9903 | 1.0097 |
| LPE (0:0/20:5) | 0.9958 | 1.0042 |
| LPE (0:0/22:6) | 1.0019 | 0.9981 |
| LPE (16:0/0:0) | 1.0000 | 1.0000 |
| LPE (18:1/0:0) | 1.0072 | 0.9928 |
| LPE (18:2/0:0) | 1.0642 | 0.9358 |
| LPE (20:4/0:0) | 1.0233 | 0.9767 |
| LPE (22:6/0:0) | 1.0389 | 0.9611 |
| PGE2 | 0.8648 | 1.1352 |
| PGF2a | 0.9866 | 1.0134 |
| Sphingosine-1-phosphate | 0.9497 | 1.0503 |
| TXB2 | 0.9084 | 1.0916 |
Factors:
| F1 | Treatment:Control |
| F2 | Treatment:Platelet activation |
